ZTS VS MDT Stock Comparison
Performance
ZTS100/100
100/100
ZTS returned 16.56% in the last 12 months. Based on SPY's performance of -13.45%, its performance is above average giving it a score of 100 of 100.
MDT59/100
59/100
MDT returned -18.84% in the last 12 months. Based on SPY's performance of -20.81%, its performance is above average giving it a score of 59 of 100.
Analyst Price Targets
ZTS75/100
75/100
21 analysts offer 12-month price targets for ZTS. Together, they have an average target of 0, the most optimistic target put ZTS at 0 within 12-months and the most pessimistic has ZTS at 0.
MDT66/100
66/100
23 analysts offer 12-month price targets for MDT. Together, they have an average target of 109.9, the most optimistic target put MDT at 165 within 12-months and the most pessimistic has MDT at 80.
Technicals
ZTS82/100
82/100
ZTS receives a 82 of 100 based on 14 indicators. 11 are bullish, 2 are bearish.
MDT14/100
14/100
MDT receives a 14 of 100 based on 14 indicators. 2 are bullish, 12 are bearish.
Earnings
ZTS53/100
53/100
ZTS has missed earnings 2 times in the last 20 quarters.
MDT66/100
66/100
MDT has missed earnings 2 times in the last 20 quarters.
Profit
ZTS78/100
78/100
Out of the last 20 quarters, ZTS has had 19 profitable quarters and has increased their profits year over year on 11 of them.
MDT70/100
70/100
Out of the last 20 quarters, MDT has had 20 profitable quarters and has increased their profits year over year on 7 of them.
Volatility
ZTS50/100
50/100
ZTS has had an average amount of volatility over the last 12 months giving it a score of 50 of 100.
MDT49/100
49/100
MDT has had a lower than average amount of volatility over the last 12 months giving it a score of 49 of 100.
Dividend
ZTS35/100
35/100
ZTS's most recent dividend was $0.12 per share, based on a share price of $174.62. It was a payout ratio of 17.39% compared to their total earnings.
MDT100/100
100/100
MDT's most recent dividend was $0.50 per share, based on a share price of $69.43. It was a payout ratio of 60.45% compared to their total earnings.
Sentiment
ZTS
"Sentiment" not found for ZTS
MDT72/100
72/100
MDT had a bullish sentiment score of 72.19% across Twitter and StockTwits over the last 12 months. It had an average of 246.36 posts, 214,816.46 comments, and 70,151.23 likes per day.
All score calculations are broken down here to help you make more informed investing decisions
ZOETIS INC. Summary
New York Stock Exchange / ZTS
Healthcare
Drug Manufacturers - Specialty & Generic
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
Medtronic plc Summary
New York Stock Exchange / MDT
Healthcare
Medical - Devices
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Power up your portfolio
Build a portfolio of your favorite stocks
Pluto makes it easy to build investing strategies and automate your portfolio
Compare Similar Companies
Compare ZTS to other companies in the same or a similar industry.